Serum neopterin levels as a diagnostic marker of hemophagocytic lymphohistiocytosis syndrome

Clinical and Vaccine Immunology

Volumn 18, Issue 4, 2011, Pages 609-614

  Ibarra, Maria F ^a,b   Klein Gitelman, Marisa ^a,b   Morgan, Elaine ^a,b   Proytcheva, Maria ^a,b   Sullivan, Christine ^c,d   Morgan, Gabrielle ^c   Pachman, Lauren M ^a,b,c   O'Gorman, Maurice R G ^a,b  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c CHILDREN S MEMORIAL RESEARCH CENTER   (United States)

^d CVS Caremark   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEOPTERIN;

ADOLESCENT; ARTICLE; BLOOD LEVEL; CHILD; CONTROLLED STUDY; DERMATOMYOSITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME IMMUNOASSAY; FEMALE; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRESCHOOL CHILD; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOASSAY; INFANT; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; NEOPTERIN; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SERUM;

EID: 79954503180     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00306-10     Document Type: Article

References (20)

1. Allen, C. E., X. Yu, C. A. Kozinetz, and K. L. McClain. 2008. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer 50:1227-1235.
2. Bohan, A., and J. B. Peter. 1975. Polymyositis and dermatomyositis. N. Engl. J. Med. 292:344-403.
3. Castillo, L., and J. Carcillo. 2009. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr. Crit. Care Med. 10:387-392.
4. De Benedetti, F., M. De Amici, L. Aramini, N. Ruperto, and A. Martini. 1993. Correlation of serum neopterin concentrations with disease activity in juvenile dermatomyositis. Arch. Dis. Child. 2:232-235.
5. Enders, A., et al. 2006. Lethal hemophagocytic lymphohistiocytosis in Hermansky- Pudlak syndrome type II. Blood 108:81-87. (Pubitemid 43990615)
6. Filipovich, A. H. 2006. Hemophagocytic lymphohistiocytosis and related disorders. Curr. Opin. Allergy Clin. Immunol. 6:410-415.
7. Gulcan, E. M., I. Tirit, A. Anil, E. Adal, and G. Ozbay. 2008. Serum neopterin levels in children with hepatitis-B-related chronic liver disease and its relationship to disease severity. World J. Gastroenterol. 14(44):6840-6843.
8. Henter, J.-I., et al. 2007. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer 48(2):124-136.
9. Humber, C., et al. 1984. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J. Exp. Med. 160:310-316.
10. Imashuku, S., et al. 2002. Low natural killer activity and central nervous system disease as a high-risk prognostic indicator for young patients with hemophagocytic lymphohistiocytosis (HLH). Cancer 94:3023-3031. (Pubitemid 34547704)
11. Imashuku, S., et al. 2001. Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J. Clin. Oncol. 19(10):2665-2673.
12. Janka, G. E. 2007. Familial and acquired hemophagocytic lymphohystiocytosis. Eur. J. Pediat. 166:95-109.
13. Kelly, A., and A. V. Ramanan. 2007. Recognition and management of macrophage activation syndrome in juvenile arthritis. Curr. Opin. Rheumatol. 19:477-481.
14. Mildvan, D., et al. 2005. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection. Clin. Infect. Dis. 40:476-479.
15. Prat, C., et al. 2008. Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia. Leuk. Lymphoma 49:1752-1761.
16. Sawhney, S., P. Woo, and K. J. Murray. 2001. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch. Dis. Child. 85:421-426.
17. Shimizu, M., et al. 14 May 2010, posting date. Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. Rheumatology. doi:10.1093/rheumatology/keq133.
18. Sucher, R., et al. 2010. Neopterin, a prognostic marker in human malignancies. Cancer Lett. 287:13-22.
19. Sumegi, J., J. Johnson, A. Filipovich, K. Zhan, and R. Marsh. 27 February 2004, posting date. Lymphoproliferative disease, X-linked. GeneReviews. http://www.ncbi.nlm.nih.gov/books/NBK1406/.
20. Tatzber, F., et al. 1991. Elevated serum neopterin levels in atherosclerosis. Atherosclerosis 2-3:203-208.